Covid and MS, . . . and other stories
BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q263 (Published 08 February 2024) Cite this as: BMJ 2024;384:q263
Covid-19 and multiple sclerosis
Post-acute sequelae of SARS-CoV-2 infection are common, but fortunately they don’t include worsening of disease in people with multiple sclerosis. In an investigation from Italy, people with multiple sclerosis who also had covid-19 between 2020 and 2021 were systematically compared with people with multiple sclerosis but no history of infection. Clinical evaluation, magnetic resonance imaging, and neuropsychological assessment detected no differences in disease activity, progression of disability, cognitive impairment, or psychiatric symptoms between the groups (J Neurol Neurosurg Psychiatry doi:10.1136/jnnp-2023-332073).
Nitrates and phosphodiesterase-5 inhibitors
A few years ago a Swedish registry study reported an unexpected finding. Men who had been treated for erectile dysfunction with phosphodiesterase-5 inhibitors …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.